Emcure Pharmaceuticals IPO: The Good and The Bad

Published: 02nd July 2024

About Emcure Pharmaceuticals

[{"selector":"#anim-e65affd1-9b16-45bb-8ec9-20662c244fcf","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2667b0f1-1e0b-47f4-bc13-6f4f72b94ee3","keyframes":{"transform":["translate3d(-113.41463%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0151a3ba-362e-4e4f-8e24-41d57cb68964","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-498c997e-ff4f-47b5-beb7-746c1b5a3bfa","keyframes":{"transform":["translate3d(-115.33547%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] The company produces off-patent generic medicines, injectables, and APIs in various therapies. India is its largest market, contributing 48% of revenue, where it leads in gynaecology and HIV antivirals .

IPO details

[{"selector":"#anim-57dc9b16-417b-41e8-886e-0b007fedb05d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d1a5bb02-27a9-4a26-9178-e8c46bba3cab","keyframes":{"transform":["translate3d(-112.80487%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Post IPO

[{"selector":"#anim-b00aa045-e385-4a02-a0a8-cd366936cf68","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c110ef8f-a094-4346-8ec9-bbe8d0ebf333","keyframes":{"transform":["translate3d(-112.80487%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Financial History

[{"selector":"#anim-0f7b8196-3124-4123-8f12-6f14179759f9","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cef8055c-a998-4947-8b8c-e8607e70f0b2","keyframes":{"transform":["translate3d(-112.80487%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Ebit is earnings before interest and tax PAT is profit after tax

Key ratios

[{"selector":"#anim-2a4f5f64-e11b-45c2-a710-2eda56681641","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d5b32f77-ef17-4d76-85d3-300115e3a757","keyframes":{"transform":["translate3d(-112.80487%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] ROE is return on equity ROCE is return on capital employed

The Good

[{"selector":"#anim-4a4c2d45-c9bd-4cfd-aa94-4ee78450cd3f [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-d9214a27-00a3-4982-bb67-ac9a11b0e887","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-94c7c403-2ec9-4f05-a3eb-6df88dfae7d4","keyframes":{"transform":["translate3d(-114.32927%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-43c74b55-f945-46ad-91e4-e517d3e87c76","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1ff6ac81-7f0f-4d18-8a3b-1dc1cfadbeb1","keyframes":{"transform":["translate3d(-115.33547%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] It has a strong presence in the domestic market with leadership in niche categories. It is among the top 10 players (in terms of market share) in multiple chronic therapeutic areas .

The Good

[{"selector":"#anim-eca8e152-6e9a-4c85-8e21-15d29312bb25 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-1853f9ac-2214-4a58-b52f-3472488124e5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a019647e-5b9f-482e-ad2e-9bdd3d824c3f","keyframes":{"transform":["translate3d(-114.63415%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d56669c3-b049-47ac-b1da-6bca1664ffe6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cc6c6920-13c0-42cb-a2e8-2b1194bd5ab7","keyframes":{"transform":["translate3d(-115.65495%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] The company enjoys operational efficiency , thanks to its vertical integration . It has 13 manufacturing facilities across India and a solid distribution network in the international market.

The bad

[{"selector":"#anim-75162998-09ad-44a3-a7d0-bb69b7e56422 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-3b7042ba-1516-43da-adf2-269c51b9eafc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9022e6a8-75ed-477a-bf93-d2b39b6ae29c","keyframes":{"transform":["translate3d(-114.63415%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ff843274-2ff5-4666-8a86-ff745695ce17","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a4fcc67c-fa92-4652-a639-96acb566c705","keyframes":{"transform":["translate3d(-115.65495%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] The company’s focus in generics is a key pitfall. To find out why, and to read the complete risk report, head to our story from the link below. IPO: Emcure Pharmaceuticals

Other Webstories

[{"selector":"#anim-85e9ecea-9d9c-43bf-822e-383fadae07ef","keyframes":{"opacity":[0,1]},"delay":200,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ecd49611-4016-4e07-915f-ff58f6635133","keyframes":{"transform":["translate3d(-125.51724%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0fcc7b39-653c-4b41-948f-0c0eb53fbbd5","keyframes":{"opacity":[0,1]},"delay":300,"duration":2000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2e86f4af-8b18-4139-9b83-a42a20d836c4","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1e0c5be3-ae1c-4081-adef-ed5bae7e89b4","keyframes":{"transform":["translate3d(-194.52735%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c40ee7fb-df7f-4cd2-b858-a3ed52750ad1","keyframes":{"opacity":[0,1]},"delay":800,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a807e908-7841-4754-9e59-e0013f626e70","keyframes":{"transform":["translate3d(-125.51724%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":800,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-91df521d-ce79-4f76-8416-ee80e5f0c450","keyframes":{"opacity":[0,1]},"delay":900,"duration":2000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7a69776b-8094-4641-91bb-da9665da3a8b","keyframes":{"opacity":[0,1]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3c51f50c-466c-476b-b8b8-6495008435cc","keyframes":{"transform":["translate3d(-194.52735%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d867c914-f60e-42ea-98de-a12620b5cb2b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-36d41a15-82f1-492c-9671-af5706a2d4de","keyframes":{"transform":["translate3d(-125.51724%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9057bce3-6bb9-4a12-8bf2-4c8af503d8c9","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f4d97a78-c678-4085-8bb6-5edb30ba4ec4","keyframes":{"transform":["translate3d(-125.51724%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Click Here

Emcure Pharmaceuticals IPO: The Good and The Bad

Emcure Pharmaceuticals IPO: The Good and The Bad

About Emcure Pharmaceuticals

About Emcure Pharmaceuticals

IPO details

Post IPO

Financial History

Key ratios

The Good

The Good

The Good

The Good

The bad

The bad

Other Webstories

This mega IPO is set to smash all records on D-Street

Akme Fintrade IPO: Quick review and analysis

To Read More